Tuberculostatics-induced systemic lupus erythematosus

Deutsche medizinische Wochenschrift
P Layer, M Engelhard

Abstract

Clinical manifestations including rheumatoid changes, lymph node swelling, fever, butterfly rash, anaemia and leukopenia had developed gradually over a period of years in a 46-year-old female patient. Due to these findings systemic lupus erythematosus (SLE) was suspected. Further diagnostic procedures revealed concomitant pulmonary tuberculosis. In the course of the tuberculostatic therapy, there occurred six episodes of marked exacerbation of drug-induced SLE signs and symptoms including fever, myalgia, swelling of joints, butterfly rash and high titers of antinuclear antibodies. These exacerbations were induced by single-agent or combination therapy with ethambutol, pyrazinamide, streptomycin and/or prothionamide and resolved readily after discontinuation of the drug(s). With concomitant use of hydroxychloroquine sulfate, a combination therapy with rifampicin and cycloserine did not give rise to further complications although the autoantibodies persisted. This treatment regimen was given until clinical cure was achieved.

Citations

Jan 25, 2014·Journal of Autoimmunity·Xiao Xiao, Christopher Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Archives of Dermatological Research
Camilla Dalle VedoveGiampiero Girolomoni
Annals of the Rheumatic Diseases
M Salazar-PáramoI García-De La Torre
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
E J Price, P J Venables
© 2021 Meta ULC. All rights reserved